ShockWave Medical, which sells medical systems used in treating cardiovascular disease, raised $97 million by offering 5.7 million shares at $17. The company had originally planned to offer 5.0 million shares at a range of $14 to $16. Additionally, insider Abiomed agreed to invest $10 million in a concurrent private placement.
ShockWave Medical plans to list on the Nasdaq under the symbol SWAV. Morgan Stanley and BofA Merrill Lynch acted as lead managers on the deal.
